Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-eligible patients with multiple myeloma: A pooled analysis of patients aged ≥65 years from both PERSEUS and GRIFFIN studies Meeting Abstract
| Authors: | Rodríguez-Otero, P.; Voorhees, P. M.; Boccadoro, M.; Laubach, J.; Einsele, H.; Sborov, D. W.; Dimopoulos, M.; Broijl, A.; Mina, R.; Spencer, A.; Schjesvold, F.; Silbermann, R.; Gay, F.; Costa, L.; Perrot, A.; Liu, Y.; Wang, J.; Sitthi-Amorn, A.; Carson, R.; Cortoos, A.; Usmani, S.; Richardson, P.; Moreau, P.; Sonneveld, P.; Kaufman, J. L. |
| Abstract Title: | Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-eligible patients with multiple myeloma: A pooled analysis of patients aged ≥65 years from both PERSEUS and GRIFFIN studies |
| Meeting Title: | 21st Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 25-28 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S242 |
| End Page: | S243 |
| Language: | English |
| ACCESSION: | WOS:001325737900425 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)02265-1 |
| Notes: | Meeting Abstract: P-363 -- Source: Wos |
